Literature DB >> 6437887

The in vitro generation of an antibacterial activity from the fat body and hemolymph of non-immunized larvae of Galleria mellonella.

P J De Verno, J S Chadwick, W P Aston, G B Dunphy.   

Abstract

A state of immunity in Galleria mellonella against the pathogen Pseudomonas aeruginosa is known to be induced by the injection of lipopolysaccharide (LPS), isolated from the homologous organism. An in vitro mixture of the LPS and whole or cell-free hemolymph from non-immunized larvae is not antibacterial. In vitro mixtures of fat body and cell-free hemolymph from non-immunized larvae, incubated at 25 degrees C for 20 hours generated a proteinaceous antibacterial activity. The generation of this activity was enhanced by the presence in the incubation mixture of LPS and/or hemocytes from non-immunized larvae. It is suggested that LPS causes the release of a hemocyte factor(s) which acts in conjunction with or directly on the fat body resulting in an enhanced production of antibacterial factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6437887     DOI: 10.1016/0145-305x(84)90086-7

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  3 in total

1.  Growth of an ovarian cell line of Galleria mellonella and its response to immune-inducing factors.

Authors:  Robert J Zakarian; Gary B Dunphy; Jean-Marie Quiot
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Nov-Dec       Impact factor: 2.416

2.  Anti-Listeria activities of Galleria mellonella hemolymph proteins.

Authors:  Krishnendu Mukherjee; Mobarak Abu Mraheil; Silke Silva; Daniela Müller; Franz Cemic; Jürgen Hemberger; Torsten Hain; Andreas Vilcinskas; Trinad Chakraborty
Journal:  Appl Environ Microbiol       Date:  2011-04-29       Impact factor: 4.792

3.  The immune response in Drosophila: pattern of cecropin expression and biological activity.

Authors:  C Samakovlis; D A Kimbrell; P Kylsten; A Engström; D Hultmark
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.